{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "12898234", "DateCompleted": {"Year": "2003", "Month": "12", "Day": "12"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2003", "Month": "07", "Day": "31"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0171-5216", "JournalIssue": {"Volume": "129", "Issue": "10", "PubDate": {"Year": "2003", "Month": "Oct"}}, "Title": "Journal of cancer research and clinical oncology", "ISOAbbreviation": "J Cancer Res Clin Oncol"}, "ArticleTitle": "Naturally occurring lignans efficiently induce apoptosis in colorectal tumor cells.", "Pagination": {"StartPage": "569", "EndPage": "576", "MedlinePgn": "569-76"}, "Abstract": {"AbstractText": ["Plant-derived lignans caused cell loss by apoptosis in colorectal adenoma and carcinoma cells. Nordihydroguaiaretic acid (NDGA), commonly used for the inhibition of lipoxygenase isoenzymes, showed the strongest growth inhibition with an IC50 of 1.9+/-0.5 microg followed by epiashantin (IC50=9.8+/-4.5 microM) and arctigenin (IC50=16.5+/-8.5 microM). The lignans caused a time- and dose-dependent loss of mitochondrial membrane potential (MMP), down regulation of the anti-apoptotic protein bcl(xl) and an increase of the apoptotic index. The time interval until loss of MMP and down modulation of bcl(xl) became evident correlated with the efficiency of growth inhibition by NDGA, epiashantin and yangambin. Bcl2 and caspase 3 were not involved. NDGA also induced a shift of the culture population to the G2/M phase of the cell cycle. With respect to these results, naturally occurring lignans could be useful in the therapy and chemoprevention of colorectal tumors."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Cancer Research, University of Vienna, Borschkegasse 8a, 1090, Vienna, Austria."}], "Identifier": [], "LastName": "Hausott", "ForeName": "B", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Greger", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Marian", "ForeName": "B", "Initials": "B"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "J Cancer Res Clin Oncol", "NlmUniqueID": "7902060", "ISSNLinking": "0171-5216"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Lignans"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipoxygenase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "7BO8G1BYQU", "NameOfSubstance": "Masoprocol"}], "MeshHeadingList": [{"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Adenoma"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Carcinoma"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Colorectal Neoplasms"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": ["drug effects"], "DescriptorName": "Intestinal Mucosa"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Lignans"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Lipoxygenase Inhibitors"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Masoprocol"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plant Structures"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Br J Pharmacol. 1997 Dec;122(7):1516-22", "ArticleIdList": ["9421304"]}, {"Citation": "Eur J Cancer. 2002 Sep;38(14):1937-45", "ArticleIdList": ["12204677"]}, {"Citation": "Nat Rev Cancer. 2001 Oct;1(1):11-21", "ArticleIdList": ["11900248"]}, {"Citation": "Biochem Biophys Res Commun. 1993 Nov 30;197(1):40-5", "ArticleIdList": ["8250945"]}, {"Citation": "Cancer Lett. 2000 Jul 3;155(1):79-88", "ArticleIdList": ["10814883"]}, {"Citation": "Jpn J Pharmacol. 1985 Mar;37(3):253-8", "ArticleIdList": ["3923244"]}, {"Citation": "Planta Med. 1995 Apr;61(2):106-12", "ArticleIdList": ["7753914"]}, {"Citation": "Biochem Pharmacol. 1994 Nov 16;48(10):1935-42", "ArticleIdList": ["7986205"]}, {"Citation": "Am J Physiol. 1993 Nov;265(5 Pt 1):C1239-46", "ArticleIdList": ["8238477"]}, {"Citation": "Kidney Int. 1987 Sep;32(3):329-34", "ArticleIdList": ["3312760"]}, {"Citation": "Anticancer Res. 1995 Mar-Apr;15(2):233-9", "ArticleIdList": ["7762989"]}, {"Citation": "Anticancer Res. 1998 Mar-Apr;18(2A):1053-7", "ArticleIdList": ["9615764"]}, {"Citation": "Eur J Pharmacol. 1987 Nov 24;144(1):101-3", "ArticleIdList": ["3125055"]}, {"Citation": "Nat Toxins. 1999;7(1):39-43", "ArticleIdList": ["10441036"]}, {"Citation": "Carcinogenesis. 2000 Sep;21(9):1655-60", "ArticleIdList": ["10964096"]}, {"Citation": "Mutat Res. 1991 Nov;261(3):153-62", "ArticleIdList": ["1719406"]}, {"Citation": "Jpn J Cancer Res. 1992 Sep;83(9):944-8", "ArticleIdList": ["1429204"]}, {"Citation": "J Biochem Toxicol. 1989 Fall;4(3):151-60", "ArticleIdList": ["2514267"]}, {"Citation": "Prostaglandins Leukot Essent Fatty Acids. 1992 Jan;45(1):21-31", "ArticleIdList": ["1546063"]}, {"Citation": "Exp Lung Res. 1998 Jul-Aug;24(4):617-28", "ArticleIdList": ["9659587"]}, {"Citation": "Biochem Pharmacol. 2001 Nov 1;62(9):1185-91", "ArticleIdList": ["11705451"]}, {"Citation": "Clin Chim Acta. 1989 Apr 14;180(3):293-301", "ArticleIdList": ["2545375"]}, {"Citation": "J Nat Prod. 2000 May;63(5):616-20", "ArticleIdList": ["10843571"]}, {"Citation": "Am J Chin Med. 1996;24(2):127-37", "ArticleIdList": ["8874669"]}, {"Citation": "Biochem Biophys Res Commun. 1999 Dec 20;266(2):392-9", "ArticleIdList": ["10600514"]}, {"Citation": "Chem Biol Interact. 1998 Oct 2;115(3):215-28", "ArticleIdList": ["9851291"]}, {"Citation": "J Natl Cancer Inst. 1981 Jun;66(6):1191-308", "ArticleIdList": ["7017215"]}, {"Citation": "J Cell Physiol. 1997 Aug;172(2):155-70", "ArticleIdList": ["9258337"]}, {"Citation": "Nutr Cancer. 1999;34(1):88-99", "ArticleIdList": ["10453447"]}, {"Citation": "Cancer Lett. 2000 Sep 29;158(1):53-9", "ArticleIdList": ["10940509"]}, {"Citation": "J Nat Prod. 1998 Dec;61(12):1482-90", "ArticleIdList": ["9868148"]}, {"Citation": "J Cancer Res Clin Oncol. 1999 Jul;125(7):379-88", "ArticleIdList": ["10394957"]}]}], "History": [{"Year": "2003", "Month": "2", "Day": "4"}, {"Year": "2003", "Month": "5", "Day": "16"}, {"Year": "2003", "Month": "8", "Day": "5", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "12", "Day": "13", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "8", "Day": "5", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12898234", "10.1007/s00432-003-0461-7"]}}], "PubmedBookArticle": []}